Loblaw Companies Limited · TSX:L
Loblaw Companies — Q2 2022 Earnings Presentation
5 slides from Loblaw Companies's earnings presentation, Jun 18, 2022
Slide 1: Supplementary Slides Q2 2022
SUPPLEMENTARY SLIDES Q2 2022 For the period ended June 18, 2022 1
Slide 2: Forward Looking Statements
FORWARD LOOKING STATEMENTS This presentation for Loblaw Companies Limited (“Loblaw” or “the Company”) contains forward-looking statements about the Company’s objectives, plans, goals, aspirations, strategies, financial condition, results of operations, cash flows, performance, prospects, opportuniti
Slide 3: Key Financial Metrics – Consolidated
KEY FINANCIAL METRICS – Consolidated Q2 2022 (In CAD millions unless otherwise noted) Q2 2022 Q2 2021 % Change (1) Consolidated Revenue $12,847 $12,491 ↑ +2.9% Adjusted EBITDA $1,499 $1,371 ↑ +9.3% Adjusted EBITDA Margin 11.7% 11.0% ↑ +70 bps Adjusted Net Earnings Avaliable to Common Shareholders $5
Slide 4: Key Financial Metrics – Retail Segment
KEY FINANCIAL METRICS – Retail Segment Q2 2022 (In CAD millions unless otherwise noted) Q2 2022 Q2 2021 % Change (1) Total Retail Revenue $12,623 $12,282 ↑ 2.8% Retail Revenue - Food $8,981 $8,878 ↑ 1.2% Retail Revenue - Drug $3,642 $3,404 ↑ 7.0% Pharmacy $1,813 $1,656 ↑ 9.5% Front Store $1,829 $1,7
Slide 5: Key Operational Metrics
KEY OPERATIONAL METRICS Q2 2022 Food Retail (Loblaw) % Change (1) Food Retail Same-Store Sales Growth ↑ +0.9% Basket Size(2) ↓ Traffic(2) ↑ Loblaw STM Square Footage Growth ≈ Industry STM Square Footage Growth ↑ Drug Retail (Shoppers Drug Mart) % Change (1) Drug Retail Same-Store Sales Growth ↑ +5.6